The Investment Whisperer
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

The Investment Whisperer

Investing

First patient dosed in Phase IIb imaging for Brain Mets

by admin April 28, 2025
April 28, 2025
First patient dosed in Phase IIb imaging for Brain Mets

Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets

Download the PDF here.

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
Binding Commitments Received for A$1.0 Million under Convertible Note Placement
next post
RHI: Acqn of royalty over Sandstone Gold Project tenements

Related Posts

Grande Portage Announces First Closing of Non-Brokered Private...

November 14, 2024

US Senate Gives Green Light to Russian Uranium...

May 2, 2024

Microsoft Unveils Expanded AI Solutions to Support Healthcare...

October 16, 2024

Silver Hammer Closes CDN$1,809,000 Fully Subscribed Non-Brokered Private...

September 19, 2025

Iron Ore Exploration Commences in the Pilbara

June 28, 2024

Gareth Soloway: Gold, Silver, Bitcoin and More —...

December 20, 2023

Top 3 Canadian Rare Earths Stocks

July 26, 2024

Significant Expansion of Stated Resources at Lake Maitland...

September 24, 2024

ChemX Granted HiPurA® HPA New Zealand Patent and...

September 23, 2024

Notice of Annual General Meeting/Proxy Form

May 3, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (1,556)
    • Investing (4,326)
    • Politics (5,731)
    • World (4,762)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: TheInvestmentWhisperer.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 TheInvestmentWhisperer.com | All Rights Reserved